Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection.

Markowitz M, Vaida F, Hare CB, Boden D, Mohri H, Hecht FM, Kalayjian RC, Conrad A, Mildvan D, Aberg J, Hogan C, Kilby JM, Balfour HH Jr, Schafer K, Richman D, Little S.

J Infect Dis. 2010 May 1;201(9):1298-302. doi: 10.1086/651664.

2.

Accuracy of serological assays for detection of recent infection with HIV and estimation of population incidence: a systematic review.

Guy R, Gold J, Calleja JM, Kim AA, Parekh B, Busch M, Rehle T, Hargrove J, Remis RS, Kaldor JM; WHO Working Group on HIV Incidence Assays.

Lancet Infect Dis. 2009 Dec;9(12):747-59. doi: 10.1016/S1473-3099(09)70300-7. Review. Erratum in: Lancet Infect Dis. 2010 Feb;10(2):82.

PMID:
19926035
3.

High specific infectivity of plasma virus from the pre-ramp-up and ramp-up stages of acute simian immunodeficiency virus infection.

Ma ZM, Stone M, Piatak M Jr, Schweighardt B, Haigwood NL, Montefiori D, Lifson JD, Busch MP, Miller CJ.

J Virol. 2009 Apr;83(7):3288-97. doi: 10.1128/JVI.02423-08. Epub 2009 Jan 7.

4.

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.

Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, Sun C, Grayson T, Wang S, Li H, Wei X, Jiang C, Kirchherr JL, Gao F, Anderson JA, Ping LH, Swanstrom R, Tomaras GD, Blattner WA, Goepfert PA, Kilby JM, Saag MS, Delwart EL, Busch MP, Cohen MS, Montefiori DC, Haynes BF, Gaschen B, Athreya GS, Lee HY, Wood N, Seoighe C, Perelson AS, Bhattacharya T, Korber BT, Hahn BH, Shaw GM.

Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7. doi: 10.1073/pnas.0802203105. Epub 2008 May 19.

5.

Assessment of recent HIV-1 infection by a line immunoassay for HIV-1/2 confirmation.

Schüpbach J, Gebhardt MD, Tomasik Z, Niederhauser C, Yerly S, Bürgisser P, Matter L, Gorgievski M, Dubs R, Schultze D, Steffen I, Andreutti C, Martinetti G, Güntert B, Staub R, Daneel S, Vernazza P.

PLoS Med. 2007 Dec;4(12):e343.

6.

The relation between symptoms, viral load, and viral load set point in primary HIV infection.

Kelley CF, Barbour JD, Hecht FM.

J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):445-8.

PMID:
17514014
7.

Western blot profile in HIV infection.

Sudha T, Lakshmi V, Teja VD.

Indian J Dermatol Venereol Leprol. 2006 Sep-Oct;72(5):357-60.

8.

A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.

Hecht FM, Wang L, Collier A, Little S, Markowitz M, Margolick J, Kilby JM, Daar E, Conway B, Holte S; AIEDRP Network.

J Infect Dis. 2006 Sep 15;194(6):725-33. Epub 2006 Aug 15.

PMID:
16941337
9.

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.

Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, Nalugoda F, Wabwire-Mangen F, Meehan MP, Quinn TC.

J Infect Dis. 2005 May 1;191(9):1403-9. Epub 2005 Mar 30.

PMID:
15809897
10.

Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.

Blattner WA, Oursler KA, Cleghorn F, Charurat M, Sill A, Bartholomew C, Jack N, O'Brien T, Edwards J, Tomaras G, Weinhold K, Greenberg M.

J Infect Dis. 2004 May 15;189(10):1793-801. Epub 2004 Apr 26.

PMID:
15122515
11.

Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.

Deeks SG, Kitchen CM, Liu L, Guo H, Gascon R, Narváez AB, Hunt P, Martin JN, Kahn JO, Levy J, McGrath MS, Hecht FM.

Blood. 2004 Aug 15;104(4):942-7. Epub 2004 Apr 29.

12.

Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence.

Kothe D, Byers RH, Caudill SP, Satten GA, Janssen RS, Hannon WH, Mei JV.

J Acquir Immune Defic Syndr. 2003 Aug 15;33(5):625-34.

PMID:
12902808
13.

Use of laboratory tests and clinical symptoms for identification of primary HIV infection.

Hecht FM, Busch MP, Rawal B, Webb M, Rosenberg E, Swanson M, Chesney M, Anderson J, Levy J, Kahn JO.

AIDS. 2002 May 24;16(8):1119-29.

PMID:
12004270
14.

Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence.

Parekh BS, Kennedy MS, Dobbs T, Pau CP, Byers R, Green T, Hu DJ, Vanichseni S, Young NL, Choopanya K, Mastro TD, McDougal JS.

AIDS Res Hum Retroviruses. 2002 Mar 1;18(4):295-307.

PMID:
11860677
15.

Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group.

Lindbäck S, Thorstensson R, Karlsson AC, von Sydow M, Flamholc L, Blaxhult A, Sönnerborg A, Biberfeld G, Gaines H.

AIDS. 2000 Oct 20;14(15):2333-9.

PMID:
11089621
16.

Immune control of HIV-1 after early treatment of acute infection.

Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK, D'Aquila RT, Goulder PJ, Walker BD.

Nature. 2000 Sep 28;407(6803):523-6.

PMID:
11029005
17.

Detection of human immunodeficiency virus type 1 (HIV-1) antibody by western blotting and HIV-1 DNA by PCR in patients with AIDS.

Jackson JB, Parsons JS, Nichols LS, Knoble N, Kennedy S, Piwowar EM.

J Clin Microbiol. 1997 May;35(5):1118-21.

18.

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion.

Mellors JW, Kingsley LA, Rinaldo CR Jr, Todd JA, Hoo BS, Kokka RP, Gupta P.

Ann Intern Med. 1995 Apr 15;122(8):573-9.

PMID:
7887550

Supplemental Content

Support Center